Skip to main content

Sevmia Cost in Canada — 2026

By GLP1Prices Editorial · Last verified July 5, 2026

Health Canada approved Sevmia (Apotex) — the first generic version of Wegovy — on June 29, 2026. No Sevmia price has been published yet. This guide will update with verified pharmacy prices the moment tracking begins.

Sevmia has no verified pharmacy prices on file yet — Health Canada approved it on June 29, 2026 and pricing has not been published. Health Canada notes generics are typically 45–90% cheaper than brand once competition builds. We track new pharmacy prices daily and will update this page automatically the moment a verified Sevmia price is confirmed.

What does Sevmia cost in Canada right now?

Sevmia is a generic semaglutide made by Apotex (developed with Orbicular Pharmaceutical Technologies), authorized by Health Canada on June 29, 2026. It is the first generic version of Wegovy and the first generic semaglutide approved in Canada for chronic weight management — referencing Wegovy (Novo Nordisk) as its brand comparator. It is the third generic semaglutide cleared in Canada overall: the earlier two, Dr. Reddy's (April 28, 2026) and Apotex's own Apo-Semaglutide Injection (May 1, 2026), reference Ozempic and cover the Type 2 diabetes indication only. See the full regulatory timeline and sourcing on our <a href="/generic-alert">generic Wegovy &amp; semaglutide approval tracker</a>.

No Sevmia price has been published yet, so this guide cannot state one. What we can say, based on published, attributed facts: Health Canada notes that generic medicines are typically 45–90% cheaper than the brand once competition builds. Separately, Canada's pan-Canadian Tiered Pricing Framework — administered through the pan-Canadian Pharmaceutical Alliance (pCPA) — caps generic list prices in steps as more manufacturers enter a market: 75% of the brand list price for the first three months with one generic on market, 55% after three months, 50% with two generics, and 35% once three or more generics are dispensing (full detail and the underlying brand reference figure are on the <a href="/generic-alert">generic-alert page</a>). Those are list-price caps for public formularies, not retail counter prices, and they describe the framework in general — not a Sevmia-specific figure.

As an honest brand anchor while Sevmia pricing is pending: brand-name Wegovy currently runs $270–$550 at the Canadian pharmacies we track (verified pharmacy prices, updated regularly — see live figures on the <a href="/drugs/wegovy">Wegovy price comparison</a>). For comparison, our tracked Apo-Semaglutide (Apotex's earlier Ozempic-referencing generic) currently runs $88 in Ontario and British Columbia, $91 in Alberta, and $99 in Quebec at Costco Pharmacy — the first tracked price for that generic appeared roughly three weeks after its Health Canada approval, which gives a rough sense of typical approval-to-first-price timing, though Sevmia's own rollout may differ.

We track pharmacy prices across Canada daily via our automated scraper and manual verification, and this guide is built to update itself the instant a verified Sevmia price is confirmed — no manual rewrite needed. In the meantime, you can <a href="/generic-alert">join the free alert</a> to be notified by email when Sevmia prices go live, or check <a href="/guides/generic-ozempic-cost-canada">our companion guide to generic Ozempic (Apo-Semaglutide) pricing</a>, the earlier Apotex generic that is already tracked with live prices.

No verified prices on file yet. Check back soon.

Frequently asked questions

What is Sevmia?
Sevmia is a generic semaglutide made by Apotex (developed with Orbicular Pharmaceutical Technologies), authorized by Health Canada on June 29, 2026. It is the first generic version of Wegovy and the first generic semaglutide approved in Canada for chronic weight management. Health Canada authorized Sevmia for patients aged 12 and older as an adjunct to a reduced-calorie diet and increased physical activity, for adults with obesity (BMI ≥ 30) or overweight (BMI ≥ 27) with at least one weight-related comorbidity, and to reduce the risk of a non-fatal heart attack in adults with established cardiovascular disease and a BMI ≥ 27 — the same regulatory facts published on our generic Wegovy tracker.
When will Sevmia be available to buy in Canada?
Availability is pending. Health Canada approval (June 29, 2026) is the regulatory clearance to sell the product, but stocking and pharmacy rollout typically follow weeks later. For a rough reference point: our tracked data shows Apotex's earlier Ozempic-referencing generic (Apo-Semaglutide) had its first verified pharmacy price appear about three weeks after its own Health Canada approval — Sevmia's rollout timeline may differ. We track new pharmacy prices daily and will update this guide the moment a verified Sevmia price appears.
How much will Sevmia cost?
No Sevmia price has been published yet, so we cannot state one. What is publicly known: Health Canada notes that generic medicines are typically 45–90% cheaper than the brand once competition builds, and Canada's pan-Canadian Tiered Pricing Framework caps generic list prices at 75% of brand for the first three months with one generic on market, 55% after three months, 50% with two generics, and 35% with three or more generics — figures already published on our generic-alert page, not extended here. As an honest brand-price anchor, Wegovy currently runs $270–$550 at the Canadian pharmacies we track.
How is Sevmia different from Apo-Semaglutide?
Both are Apotex generic semaglutide products, but they reference different brand comparators. Apo-Semaglutide Injection (approved May 1, 2026) references Ozempic and is authorized for the Type 2 diabetes indication. Sevmia (approved June 29, 2026) references Wegovy and is authorized for chronic weight management, per the regulatory facts on Health Canada's approval notice. Apo-Semaglutide already has verified pharmacy prices tracked on our generic Ozempic price guide; Sevmia does not yet.
Will my provincial drug plan cover Sevmia?
Coverage status is not yet determined and will vary by province and plan, as it did for the earlier generic semaglutide approvals. Public plan listing decisions are made independently by each province, and the pCPA negotiates public-plan pricing separately from Health Canada's regulatory approval. Check your provincial formulary directly once Sevmia is listed rather than assuming coverage.
Can my pharmacist substitute Sevmia for Wegovy automatically?
Whether a pharmacist can substitute Sevmia for a Wegovy prescription without a new prescription depends on your province's interchangeability rules and your prescriber's instructions. This is a province- and pharmacist-specific determination — confirm the details with your pharmacist or prescriber once Sevmia is stocked in your area. We do not offer clinical or substitution advice.
Will Sevmia prices appear on GLP1Prices.ca?
Yes. We track Canadian pharmacy prices daily via our automated scraper and manual verification, covering every drug in our catalog including Sevmia. This guide is built to update itself automatically the moment a verified Sevmia price is confirmed — no manual rewrite required. Join the free alert to get an email the moment Sevmia prices go live, or check the Sevmia price page directly.

How we verify these prices

This guide will list only community-submitted (verified against the original pharmacy listing or receipt) or phone-confirmed prices once tracking begins. Read more about our verification methodology.

Update log

  • Guide published — pre-launch edition. No verified Sevmia prices on file yet.
Check your insurance coverage